Global map > Innovations > East Asia > Taiwan > Taipei City > Medigen Vaccine Biologics Corp
Medigen Vaccine Biologics Corp icon
In collaboration with the US NIH/NIAID and their solid technology based on culmination of over 15 years of research on coronavirus, MVC develops SARS-CoV-2 vaccine with genetically modified Spike protein as antigen, making it more stable and highly immunogenic. MVC is conducting animal studies and strives to enter human clinical trials in full speed.
Loading startups...